65 episodes

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

Molecule to Market: Inside the outsourcing space molecule2market

    • Science
    • 5.0 • 18 Ratings

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

    Roundtable: M&A trends in CDMO

    Roundtable: M&A trends in CDMO

    In this special roundtable episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:


    Jean-Jacques Mondoloni, Managing Partner WOMBAT CAPITAL


    Mark Quick, Executive Vice President Corporate Development at Recipharm


    Gerry Cox, Vice President at Pace Life Sciences


    Your host, Raman Sehgal, discusses M&A trends in the pharmaceutical and biotechnology supply chain, covering:


    What a real-life M&A deal in outsourcing looks like from the buyer, seller and advisor angle.

    How the dynamics of M&A have changed over the last decade given the fragmented marketplace alongside increased funding, PE-interest and a pandemic spotlight now on the sector.

    Dizzying multiples, the fight for assets and key factors driving deals and valuations in contract services.

    Predictions from the panel around the future of deal flow in the outsourcing space... will the current velocity continue?


    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!


    Molecule to Market is funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.


    We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at tryzymewire.com

    • 57 min
    The UK’s hidden life science gem

    The UK’s hidden life science gem

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michelle Duggan, Inward Investment Manager, Invest North East England.


    Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michelle, covering:


    Why is North East England becoming a UK hot spot for Health and Life Sciences.

    Collaborating and breaking down barriers to help create a super cluster of life sciences.

    The academic and industrial heartbeat that makes the region so attractive to CDMOs and major supply chain players.


    Michelle Duggan has been an inward investment manager at invest North East England since January 2021. In 2016 to 2020 she was previously appointed as Partnership manager of Newcastle University where she was responsible for cultivating and maintaining relationships among business partners. 


     


    Her devotion to the North East is unmatched across her extensive career. With her other previous position as economic advisor at North East Local Enterprise Partnership she helped place where businesses invest, grow and prosper - delivering more and better jobs for everyone.


     


    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!


     


    Molecule to Market is funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.


     


    We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at tryzymewire.com

    • 28 min
    Meet the potent powder expert

    Meet the potent powder expert

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Eccles, Chief Executive Officer at ChargePoint Technology. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering:


    The journey from a management buy-out (MBO) to running a £20m,100-person, global business.

    Benefit of investing in technology within sterile environments to avoid cross contamination and prevent expensive downtime.

    A perfect storm of market factors that are driving demand for ChargePoint and its products, including the explosion of facility investments in the CDMO space.

    The shift towards single use technologies yet the need to combat plastic usage. And how sustainability will become a core business issue and a major valuation metric for buyers.

    An inside look into the virtual process of ChargePoint’s recent acquisition by Arcline Investment Management and the dizzying level of buyers that were in the running for the fast-growing business.


    Chris has managed the global business expansion of ChargePoint across all functions including offices based in the UK, Europe, America and Far East. His background in manufacturing management and precision engineering was instrumental in determining the strategy to outsource manufacturing through strategic acquisitions and equipment investments, including the investment in cleanroom technology and disposable manufacturing processes in 2019 and the managed recruitment of technical resources.


    As CEO of ChargePoint, Chris has developed a strong positive culture within ChargePoint, focussed on honesty, integrity, and quality which is ultimately reflected in customer satisfaction, employee retention. And the recent successful acquisition of ChargePoint by Arcline Investment Management.





    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!





    Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.





    We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at tryzymewire.com

    • 40 min
    Physician. Scientist. Entrepreneur.

    Physician. Scientist. Entrepreneur.

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Go van Dam, CEO & Founder at TRACER.


    Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Go, covering:


    The value of micro-dosing and fluorescent imaging in small patient populations at the preclinical proof of concept phase, and the benefits to investors, biotech and big pharma.

    The journey of stepping out of the operating theatre and into the boardroom. Taking an idea from the academic breeding ground and scaling into an industrial level so it has greater application.

    How the academia and industry ecosystem can collaborate, share and partner for the greater good.

    The need to observe, talk and learn from others. And it’s OK to copy and paste what you like in others.


    Prof. Go van Dam is the CEO and Co-Founder of TRACER, a Clinical Research Organisation specialising in generating fast and accurate in-human data with nuclear and optical molecular imaging techniques, even before the classical Phase I-III studies. Go is seen as a pioneer in the optical imaging field with groundbreaking research to his name. 


     


    Go originated as a surgeon oncologist and professor of Surgery at Groningen University. He trained at Harvard, the Mayo Clinic and NCI. Go executed and published the 1st in-human application of targeted fluorescence imaging in 2011 (Nature Medicine) and published more than 140 papers predominantly about clinical translation of innovative targeted optical molecular imaging. He currently focuses on utilising his validated optical imaging expertise in the life sciences industry to reduce R&D innovation costs, shorten time-to-market, and increased efficiency for innovative drug development.


    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!





    Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.





    We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at tryzymewire.com


     

    • 33 min
    Hollywood DVDs to biotech drugs

    Hollywood DVDs to biotech drugs

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Devendra Mishra, Executive Director and Founder at Bio Supply Management Alliance (BSMA).


    Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Devendra, covering:


    Being at the birth of biotech becoming a business and creating a network of 10k+ supply chain professionals.

    How we have just been through the most creative and productive period in healthcare in the last 100 years. Government bodies, private companies and academia collaborating to break down barriers and accelerate growth.

    The similarities of developing a movie and developing a new drug product. And what the life science supply chain can learn from digital collaboration and data analytics that occur in Hollywood.


    Devendra is an internationally recognized authority on supply chain management thinking and practice. For two decades he has been committed to the adoption of disruptive technologies in media and entertainment as well as life sciences as an adjunct professor of Supply Chain Management at Pepperdine University.


     


    Since 2004, the Mission of BSMA has been to advance the supply chain of Life Science through collaboration and adoption of technology. Positioned in the USA, Europe and India, its members are all the major biotech and pharma companies of the world.


     


    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!


     


    Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.


     


    We are also proudly supported by Zymewire which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at - zymewire.com 


     

    • 38 min
    The big pharma sourcing specialist

    The big pharma sourcing specialist

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Daniel Hogan, External Manufacturing Team Lead for the Americas at Bayer Pharmaceuticals.


    Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Daniel, covering:


    Managing a portfolio of 30-50 CMO partners across OSD, aerosols, topicals and liquids. And why due diligence and careful CMO selection is vital given its 10 x harder to exit a site.

    Some of the fundamental differences and similarities between sourcing as a big pharma and a small biotech.

    What good and bad relationships look like with an outsourced partner.

    The proliferation and availability of vendors in the outsourcing space. And why there is always room for CDMOs/CMOs with novel capabilities.

    Timeless advice for CDMOs/CMOs/CPOs in building relationships and revenue with big pharma.


    With almost 20 years in the sector, Dan’s technical knowledge encompasses diverse pharmaceutical dosage forms with experience manufacturing and formulating a wide range of products for oral, topical, and parenteral administration. He thrives on contributing to complex products with the potential to cure people of disease, enabling them to lead lives of health and wellness.


    Leading a team of experienced engineers responsible for the technology interface between Bayer and Contract Manufacturing Organizations (CMOs), Dan currently manages the manufacturing of a diverse dosage, multimillion-dollar product portfolio while providing guidance on activities such as process optimization, technology transfer from Bayer research and development to CMOs and validation of processes at commercial scale at various CMOs.


    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!


    Molecule to Market is funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.


    We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at - zymewire.com


     

    • 43 min

Customer Reviews

5.0 out of 5
18 Ratings

18 Ratings

Maryhuston ,

Awesome!

Truly awesome to listen Raman’s shows. He brings out the best of the bests. Thoroughly enjoy his show! Good luck Raman!

C-Lo-77 ,

Great insights!

Raman does a wonderful job with capturing insights across the industry and with experts.

Adam g 1991 ,

Great outsourcing market info

Very very smart mann

Top Podcasts In Science

Hidden Brain
Alie Ward
Jordan Harbinger
Neil deGrasse Tyson
Sam Harris
Bret Weinstein & Heather Heying

You Might Also Like

Tim Ferriss: Bestselling Author, Human Guinea Pig
Matt Pillar
Erin Harris